Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
16.04. | EVOME MEDICAL TECHNOLOGIES INC. - 10-K, Annual Report | 1 | SEC Filings | ||
15.04. | EVOME MEDICAL TECHNOLOGIES INC. - 8-K, Current Report | 1 | SEC Filings | ||
12.04. | Evome Medical Technologies Inc: Evome Medical talks credit agreement with Pathward | 1 | Stockwatch | ||
12.04. | Evome Medical Technologies Inc.: Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled | 54 | GlobeNewswire (Europe) | NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the "Company" or "Evome") highlighted the strengthening credit relationship with Pathward, N.A. ("Pathward"), the Company's... ► Artikel lesen | |
05.04. | Evome Medical Technologies has a 360% upside, Leede says | 1 | Cantech Letter | ||
02.04. | Evome Medical Technologies Inc: Evome Medical to sell Simbex for $4.83-million | 1 | Stockwatch | ||
02.04. | Evome Medical Technologies Inc: Evome Medical Technologies to resume at 9 a.m. PT | 1 | Stockwatch | ||
02.04. | Evome Medical Technologies Inc.: Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt | 1 | GlobeNewswire (USA) | ||
02.04. | Evome Medical Technologies Inc: Evome Medical Technologies halted at 8:13 a.m. PT | 1 | Stockwatch | ||
01.04. | EVOME MEDICAL TECHNOLOGIES INC. - 8-K, Current Report | 1 | SEC Filings | ||
01.04. | EVOME MEDICAL TECHNOLOGIES INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
01.04. | Evome Medical Technologies Inc: Evome estimates 2023 revenues at $62.6-million | 1 | Stockwatch | ||
01.04. | Evome Medical Technologies Inc.: Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023 | 100 | GlobeNewswire (Europe) | NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announced today preliminary annual financial results for the year ending December 31, 2023.... ► Artikel lesen | |
27.02. | Evome Medical Technologies Inc.: Evome Medical Engages ICP Securities Inc. for Automated Market Making Services | 2 | GlobeNewswire (USA) | ||
23.02. | EVOME MEDICAL TECHNOLOGIES INC. - 8-K, Current Report | 1 | SEC Filings | ||
15.02. | Evome Medical Technologies Inc: Evome adds two to board, says transformation imminent | 1 | Stockwatch | ||
15.02. | Evome Medical Technologies Inc.: Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman | 212 | GlobeNewswire (Europe) | NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announces the appointment of two senior healthcare executives to its Board of Directors.? Mr.... ► Artikel lesen | |
08.02. | Evome Medical Technologies Inc: Evome Medical extends $3.29M (U.S.) Simbex debt to 2025 | - | Stockwatch | ||
08.02. | Evome Medical Technologies Inc.: Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by | 186 | GlobeNewswire (Europe) | NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") has executed a non-binding letter of intent (LOI) to extend acquisition debt of US$3,294,440... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
RXSIGHT | 54,92 | 0,00 % | RxSight, Inc. - 8-K, Current Report | ||
NEWGENIVF GROUP | 2,230 | 0,00 % | NewGenIVF Limited: NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings | BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 23,000 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,800 | 0,00 % | Where Privia Health Gr Stands With Analysts | ||
SIEMENS HEALTHINEERS | 52,78 | +1,19 % | DAX & Co: Sartorius, Netflix, Siemens Healthineers, LVMH, Aixtron und Rheinmetall im Fokus | Der DAX hat am Mittwoch seine Gewinne bis zum Handelsende wieder vollständig abgegeben. Am Ende ging er mit einem Plus von 0,02 Prozent auf 17.770,02 Zähler über die Ziellinie. Am heutigen Donnerstag... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 53,75 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
PROGYNY | 32,370 | 0,00 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
ATRICURE | 23,150 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
FRESENIUS | 27,790 | +0,47 % | DAX-Check LIVE: Adidas, Continental, Covestro, Fresenius, Infineon, Porsche AG im Fokus | Dem DAX gelang es gestern nicht sich aus der Minuszone herauszuarbeiten. Er ging mit einem Verlust von 1,44 Prozent aus dem Handel. Damit schloss er bei 17.766 Punkten. Worauf es jetzt für den DAX ankommt... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 6,110 | 0,00 % | LifeStance Health Group, Inc.: LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024 | ||
GERRESHEIMER | 102,20 | +0,20 % | Gerresheimer: Aktie im Aufwind - das steckt dahinter | Das Analystenhaus Stifel hat am Mittwoch seine Einschätzung zur Gerresheimer-Aktie erneuert und spricht nun eine klare Kaufempfehlung aus. Die Aktie ist am Vormittag stark gefragt und gehört zu den... ► Artikel lesen | |
ADAPTHEALTH | 9,795 | 0,00 % | Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank | ||
FRESENIUS MEDICAL CARE | 39,470 | -1,08 % | Fresenius und FMC: Aktien im Aufwind - das beflügelt | Die Aktien von Fresenius und ihrer ehemaligen Tochtergesellschaft Fresenius Medical Care (FMC) zeigen am Montag eine robuste Performance. Die Fresenius-Aktie erreichte zwischenzeitlich den höchsten... ► Artikel lesen | |
LIFEMD | 10,890 | 0,00 % | LifeMD, Inc.: LifeMD Reports Fourth Quarter 2023 Results | Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period.Adjusted EPS of $0.15 per share compared with $0.02 in the year-ago... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 10,700 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Recent Acquisitions That Continue to Drive Growth and Value | LOUISVILLE, Ky., March 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or "BrightSpring Health Services") (NASDAQ: BTSG), a leading provider of home and community-based... ► Artikel lesen |